Navigation Links
Institute for regenerative medicine to lead national effort to aid wounded warriors
Date:9/27/2013

WINSTON-SALEM, N.C. Sept. 27, 2013 The Institute for Regenerative Medicine at Wake Forest University School of Medicine (Wake Forest Baptist Medical Center) has been selected to lead the second phase of the Armed Forces Institute of Regenerative Medicine (AFIRM). The five-year, $75 million federally funded project focuses on applying regenerative medicine to battlefield injuries.

Anthony Atala, M.D., director of the Wake Forest Institute for Regenerative Medicine, is the lead investigator for AFIRM-II. He will direct a consortium of more than 30 academic institutions and industry partners. Assisting him is co-director Rocky S. Tuan, Ph.D., associate director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh.

The first phase of AFIRM, which began in 2008, resulted in clinical studies of face transplantation, minimally invasive surgery for craniofacial injuries, a lower-dose anti-rejection regimen after kidney transplantation, scar reduction treatments, fat grafting for reconstructive surgery and new treatments for burns. Atala was co-leader of AFIRM-I, which was comprised of two research consortiums.

"The AFIRM-I teams were charged with conducting at least one clinical study of a new treatment for wounded warriors," said Atala. "Instead, due to their expertise, collaborative spirit and dedication to the mission, there were more than 10 clinical studies of potential new therapies. We are honored to have the opportunity to continue this important work to benefit those who serve our country."

Regenerative medicine is a science that takes advantage of the body's natural healing powers to restore or replace damaged tissue and organs. Therapies developed by AFIRM can also benefit people in the civilian population. AFIRM is a "results-focused" program that not only funds scientific research, but requires that discoveries be tested and compared so that the most promising therapies can be brought to clinical trials.

"When warriors come back from the battlefield with serious life-changing injuries, it is our job to find new and innovative ways to help them. Ultimately, we'd like to create new treatments to repair these severe injuries as if they never happened," said Maj. Gen. Joseph Caravalho Jr., commanding general of the U.S. Army Medical Research and Materiel Command and Fort Detrick. "The science of regenerative medicine is one of the ways we fulfill our promise to service members who put themselves in harm's way, that we will work our hardest and do our very best to take care of them."

The AFIRM-II team will focus on developing clinical therapies over the next five years focusing on:

  • Restoring function to severely traumatized limbs
  • Reconstruction for facial and skull injuries through tissue regeneration
  • Skin regeneration for burn injuries
  • New treatments to prevent rejection of "composite" transplants such as face and hands
  • Reconstruction of the genital and urinary organs and lower abdomen including the bladder, anal sphincter and external genitalia

Members of the AFIRM-II team, known as the Warrior Restoration Consortium, are Brigham and Women's Hospital, Case Western Reserve University, Cleveland Clinic, Georgia Institute of Technology, Jewish Hospital, Johns Hopkins University, Livionex Inc., Massachusetts General Hospital, Mayo Clinic, New York University School of Medicine, Northwestern University, Oregon Health & Science University, Radboud University Medical Center, Research Foundation of SUNY, Rice University, Stanford University School of Medicine, Rutgers -The State University of New Jersey, Southwest Research Institute, Stratatech Corporation, The Ohio State University College of Medicine, Tufts University, University of California, Los Angeles, University of Cincinnati, University of Connecticut, University of Florida, University of Louisville School of Medicine, University of Maryland School of Medicine, University of Michigan, University of Pittsburgh, UW Medicine, Vanderbilt University Medical Center, Wake Forest University School of Medicine (Wake Forest Baptist Medical Center).

The academic-industry team will work with health professionals at the U.S. Army Institute of Surgical Research and Walter Reed National Military Medical Center to develop new treatments for wounded soldiers. Government sponsors of AFIRM are the U.S. Army Medical Research and Materiel Command, the Office of Naval Research, the Air Force Medical Service, the Office of Research and Development - Department of Veterans Affairs, the National Institutes of Health, and the Office of the Assistant Secretary of Defense for Health Affairs.


'/>"/>

Contact: Karen Richardson
krchrdsn@wakehealth.edu
336-716-4453
Wake Forest Baptist Medical Center
Source:Eurekalert

Related medicine news :

1. New Findings from Miraca Life Sciences Research Institute Slated for Release at ACG 2013
2. Feinstein Institute Researcher Organizes LI Alzheimer’s Consortium
3. Southwest Skin and Cancer Institute Employs Botox for New Indications
4. Landmark San Diego Dermatology Practice Receives Renewal of Institute for Medical Quality Certification
5. Memorial Cancer Institute to Demonstrate Highly Reliable, Highly Efficient Culture at ASTRO Conference
6. Chapman Orthopedic Institute Sponsors No-Cost Arthritis & Joint Pain Seminar
7. National Latina Institute for Reproductive Health wins 2013 Latinos in Tech Innovation and Social Media Award for best nonprofit
8. National Personal Training Institute Announces Two New Locations in Pittsburgh and New York City
9. Quantum Institute has launched exclusive editing services for scholars in New Zealand
10. Feinstein Institute to Receive $330,000 Grant to Support Research of Childhood Cancer
11. NIH awards grant to Banner Alzheimers Institute for major prevention study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2020)... ... July 01, 2020 , ... Dexur’s analysis ... OrthoColorado Hospital , Porter Adventist Hospital , and Sky Ridge Medical ... Hip & Knee Replacement. Dexur’s value analysis tracks a patient’s episode of care from ...
(Date:7/1/2020)... STATION, Texas (PRWEB) , ... July 01, 2020 ... ... solutions, announced today that it has been selected by Codiak BioSciences to support ... The PODs will provide the cleanroom infrastructure for the drug substance and product ...
(Date:6/28/2020)... ... June 26, 2020 , ... ... the Inland Empire’s premier residential addiction treatment center, proudly announces that it has ... includes special preparation for recovery in a world affected by Covid-19. , When ...
(Date:6/28/2020)... ... June 28, 2020 , ... World Allergy Organization ... Allergy Week, from June 28 to July 4, 2020, to the importance of ... short for “coronavirus disease 2019”, is a disease spreading around the world caused ...
(Date:6/24/2020)... ... June 24, 2020 , ... At Allerio we have chosen ... telemedicine and remote communications. We knew it had to be portable, it had to ... it just has to work. , We are proud to announce that Allerio has ...
Breaking Medicine News(10 mins):
(Date:6/28/2020)... NEW YORK (PRWEB) , ... June 26, 2020 ... ... this June’s 'Lung Health' campaign. The campaign brings together patients, healthcare providers, advocates, ... innovations in diagnostics, prevention, and treatment for these devastating respiratory conditions. ...
(Date:6/25/2020)... (PRWEB) , ... June 25, 2020 , ... ... Competition by Innovate UK to build a distributed ledger platform to store COVID-19 ... of August, Billon will provide a fully functioning prototype for publishing, sharing and ...
(Date:6/25/2020)... , ... June 25, 2020 , ... The Heritage Downtown ... had zero cases of COVID-19. With over 100,000 positive cases of the coronavirus in ... senior citizens who reside at The Heritage Downtown, their family members, as well as ...
Breaking Medicine Technology: